171 related articles for article (PubMed ID: 38705941)
1. Does Sample Size, Sampling Strategy, or Handling of Concentrations Below the Lower Limit of Quantification Matter When Externally Evaluating Population Pharmacokinetic Models?
El Hassani M; Liebchen U; Marsot A
Eur J Drug Metab Pharmacokinet; 2024 Jul; 49(4):419-436. PubMed ID: 38705941
[TBL] [Abstract][Full Text] [Related]
2. Optimal sampling times for a drug and its metabolite using SIMCYP(®) simulations as prior information.
Dumont C; Mentré F; Gaynor C; Brendel K; Gesson C; Chenel M
Clin Pharmacokinet; 2013 Jan; 52(1):43-57. PubMed ID: 23212609
[TBL] [Abstract][Full Text] [Related]
3. Vancomycin: An analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population.
Duong A; El Gamal A; Bilodeau V; Huot J; Delorme C; Poudrette J; Crevier B; Marsot A
Pharmacotherapy; 2024 Jun; 44(6):425-434. PubMed ID: 38803279
[TBL] [Abstract][Full Text] [Related]
4. Towards precision dosing of vancomycin: a systematic evaluation of pharmacometric models for Bayesian forecasting.
Broeker A; Nardecchia M; Klinker KP; Derendorf H; Day RO; Marriott DJ; Carland JE; Stocker SL; Wicha SG
Clin Microbiol Infect; 2019 Oct; 25(10):1286.e1-1286.e7. PubMed ID: 30872102
[TBL] [Abstract][Full Text] [Related]
5. External Validation of Model-Based Dosing Guidelines for Vancomycin, Gentamicin, and Tobramycin in Critically Ill Neonates and Children: A Pragmatic Two-Center Study.
Hartman SJF; Orriëns LB; Zwaag SM; Poel T; de Hoop M; de Wildt SN
Paediatr Drugs; 2020 Aug; 22(4):433-444. PubMed ID: 32507958
[TBL] [Abstract][Full Text] [Related]
6. Vancomycin in Pediatric Patients with Solid or Hematological Malignant Disease: Predictive Performance of a Population Pharmacokinetic Model and New Optimized Dosing Regimens.
Marsot A; Gallais F; Galambrun C; Coze C; Blin O; Andre N; Guilhaumou R
Paediatr Drugs; 2018 Aug; 20(4):375-381. PubMed ID: 29736878
[TBL] [Abstract][Full Text] [Related]
7. Vancomycin dosing: assessment of time to therapeutic concentration and predictive accuracy of pharmacokinetic modeling software.
Nunn MO; Corallo CE; Aubron C; Poole S; Dooley MJ; Cheng AC
Ann Pharmacother; 2011 Jun; 45(6):757-63. PubMed ID: 21652786
[TBL] [Abstract][Full Text] [Related]
8. Effect of analytical inaccuracy on dose adjustment for vancomycin, amikacin, and tobramycin using the Abbottbase Pharmacokinetic Systems.
Zaera S; Hermida J; Tutor JC
Ther Drug Monit; 2002 Dec; 24(6):696-700. PubMed ID: 12451284
[TBL] [Abstract][Full Text] [Related]
9. Assessing Predictive Performance of Published Population Pharmacokinetic Models of Intravenous Tobramycin in Pediatric Patients.
Bloomfield C; Staatz CE; Unwin S; Hennig S
Antimicrob Agents Chemother; 2016 Jun; 60(6):3407-14. PubMed ID: 27001806
[TBL] [Abstract][Full Text] [Related]
10. Initial vancomycin dosing protocol to achieve therapeutic serum concentrations in patients undergoing hemodialysis.
Zelenitsky SA; Ariano RE; McCrae ML; Vercaigne LM
Clin Infect Dis; 2012 Aug; 55(4):527-33. PubMed ID: 22573855
[TBL] [Abstract][Full Text] [Related]
11. Target concentration intervention is needed for tobramycin dosing in paediatric patients with cystic fibrosis--a population pharmacokinetic study.
Hennig S; Norris R; Kirkpatrick CM
Br J Clin Pharmacol; 2008 Apr; 65(4):502-10. PubMed ID: 17995972
[TBL] [Abstract][Full Text] [Related]
12. Systematic external evaluation of reported population pharmacokinetic models of vancomycin in Chinese children and adolescents.
Lv C; Lu J; Jing L; Liu TT; Chen M; Zhang R; Li C; Zhou S; Wei Y; Chen Y
J Clin Pharm Ther; 2021 Jun; 46(3):820-831. PubMed ID: 33751618
[TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetic model of Vancomycin based on therapeutic drug monitoring data in critically ill septic patients.
Kovacevic T; Miljkovic B; Kovacevic P; Dragic S; Momcicevic D; Avram S; Jovanovic M; Vucicevic K
J Crit Care; 2020 Feb; 55():116-121. PubMed ID: 31715528
[TBL] [Abstract][Full Text] [Related]
14. Is there a multinational consensus of tobramycin prescribing and monitoring for cystic fibrosis? Survey of current therapeutic drug monitoring practices in USA/Canada, UK/Ireland, and Australia/New Zealand.
Larcombe R; Coulthard K; Eaton V; Tai A; Reuter S; Ward M
Eur J Hosp Pharm; 2024 Jun; 31(4):301-306. PubMed ID: 36600520
[TBL] [Abstract][Full Text] [Related]
15. A Model Averaging/Selection Approach Improves the Predictive Performance of Model-Informed Precision Dosing: Vancomycin as a Case Study.
Uster DW; Stocker SL; Carland JE; Brett J; Marriott DJE; Day RO; Wicha SG
Clin Pharmacol Ther; 2021 Jan; 109(1):175-183. PubMed ID: 32996120
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the Predictive Performance Between Cystatin C and Serum Creatinine by Vancomycin via a Population Pharmacokinetic Models: A Prospective Study in a Chinese Population.
Zhang R; Chen M; Liu TT; Lu JJ; Lv CL
Eur J Drug Metab Pharmacokinet; 2020 Feb; 45(1):135-149. PubMed ID: 31541402
[TBL] [Abstract][Full Text] [Related]
17. Monitoring of a single post-infusion blood sample to estimate the actual peak and trough concentration of tobramycin in critically ill patients.
Reimann IR; Meier-Hellmann A; Traut T; Reinhart K; Hoffmann A
Exp Toxicol Pathol; 2003 Jun; 54(5-6):493-8. PubMed ID: 12877363
[TBL] [Abstract][Full Text] [Related]
18. Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring.
Zhao W; Lopez E; Biran V; Durrmeyer X; Fakhoury M; Jacqz-Aigrain E
Arch Dis Child; 2013 Jun; 98(6):449-53. PubMed ID: 23254142
[TBL] [Abstract][Full Text] [Related]
19. Optimisation of vancomycin exposure in neonates based on the best level of evidence.
Dao K; Guidi M; André P; Giannoni E; Basterrechea S; Zhao W; Fuchs A; Pfister M; Buclin T; Csajka C
Pharmacol Res; 2020 Apr; 154():104278. PubMed ID: 31108184
[TBL] [Abstract][Full Text] [Related]
20. Tobramycin a Priori Dosing Regimens Based on PopPK Model Simulations in Critically Ill Patients: Are They Transferable?
Duong A; Simard C; Williamson D; Marsot A
Ther Drug Monit; 2023 Oct; 45(5):616-622. PubMed ID: 36917735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
